Author： Gex-Fabry M.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.24, Iss.13, 2001-01, pp. : 947-959
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US FDA addresses postmarketing drug surveillance concerns
Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. :
Access to resources
Recommend
US FDA addresses postmarketing drug surveillance concerns
Inpharma, Vol. 1, Iss. 1466, 2004-01 ,pp. :
Maraviroc potential drug-drug interactions
Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. :
Transporter-mediated drug––drug interactions
By Müüller Fabian Fromm Martin F
Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. :